INTRODUCTION INTRODUCTION
His hemoglobin was 11.5 g%; total and differential white blood counts were normal (TC-8500, N-61, L-39). Erythrocyte Cutaneous lesions of leukemia can be classified into two sedimentation rate (ESR) was 35 mm at the end of 1 hour. Liver groups, leukemids or non-specific lesions and true leukemic and renal function tests, X-ray chest / skull and abdominal infiltrations or specific lesions (leukemia cutis). Leukemia sonography did not reveal any abnormality. Enzyme-linked cutis (LC) is frequently seen in acute myelogenous leukemia immunosrbent assay (ELISA) for human immunodeficiency (AML) and its appearance with respect to bone marrow virus (HIV) was negative. Skin biopsy showed an atrophic involvement is variable. Aleukemic presentations have been epidermis, Grenz zone and a diffuse infiltrate of small round reported where the first manifestation of leukemia was in cells in the dermis [ Figure 2 ]. These cells were uniformly skin with a normal peripheral blood count. [1, 2] We report a stained with a slight rim of cytoplasm, large nucleus, case of localized myeloid sarcoma with an initial aleukemic fine chromatin and one to two nucleoli. A differential presentation in a young adult male. diagnosis of myeloid sarcoma or malignant lymphoma was considered. However, a bone marrow biopsy done to rule CASE REPORT CASE REPORT A 22 year old male presented with asymptomatic swelling on the scalp of 6 months duration. There was no history of trauma, weight loss, bleeding or any systemic illness in the past. Local examination revealed a hard nodular swelling 10 x 8 x 2 cm on the vertex [ Figure 1 ] along with cervical lymphadenopathy. The rest of the systemic examination was normal. A clinical differential diagnosis of cylindroma, lymphoma and cutaneous metastasis was considered.
out an underlying hemopoietic malignancy was normal. The patient was referred to Tata Memorial Hospital for further management. A diagnosis of myeloid sarcoma was favored as against lymphoma due to absence of cleaved nuclei and follicular pattern in the infiltrate. Immunohistochemistry was done to look for myeloid infiltration in the deposits and it showed strong CD43 and focal CD68 positivity. Similar findings were obtained from lymph node biopsy suggesting the presence of acute myelomonocytic leukemia. However, repeated peripheral blood counts and bone marrow examinations were normal. It was thus an aleukemic presentation of leukemia cutis. Excision and radiotherapy were planned. However, the patient had a sudden bleeding episode with a fatal outcome that occurred within 3 months of the diagnosis of cutaneous lesions.
DISCUSSION DISCUSSION
of single or multiple nodular tumor masses called granulocytic sarcoma which was seen in our patient. [5] Granulocytic sarcoma is an uncommon localized tumor composed of immature cells of granulocytic series. It was initially described in 1823 and its association with leukemia was recognized in 1893. It was earlier termed chloroma due to the green appearance resulting from the presence of myeloperoxidase in the immature myeloid cells. The term granulocytic sarcoma was coined in 1966 by Rappaport following the description of lesions which were not green (exposure to air or fixation in formalin causing loss of color). The recent terminology is myeloid sarcoma since not all myeloid leukemias are derived from granulocytes.
[6] Other names include extramedullary myeloid tumor, myeloblastoma or specific myelogenous infiltrations. It occurs in different clinical settings-as a harbinger of AML in nonleukemic patients; in association with myelodysplastic / myeloproliferative disorders with impending blast crisis; in association with AML. Myeloid sarcoma is frequently associated with the 8; 21 translocation in AML and has a less favorable prognosis. [7] The common sites of predilection are bone, periosteum, soft tissues of head and neck orbit, lymph nodes and skin. Bilateral presentation in the breast has also been documented and is due to the tropism of circulating tumor cells for breast tissue. [8] Myeloid sarcoma of prostate causing urinary obstruction in an eight year old child has been reported as an unusual LC is a rare condition of poor prognostic significance. It can manifest in a variety of leukemia subtypes, hence the exact overall incidence is unclear. In most cases of LC, systemic disease precedes it; only 7% of cases are aleukemic and 13% of LC cases are seen in AML. [3] In a retrospective study, Baer et al. reviewed 18 cases of AML with LC, wherein the skin manifestations were seen either at diagnosis or during relapse. [4] Only 2 patients had LC antedating bone-marrow involvement.
Aleukemic LC has been termed as primary extramedullary leukemia. [3] Detection of extramedullary sites is important for presentation of AML.
[6] Clinically, myeloid sarcoma involving skin presents as firm nodular masses of variable sizes which do not ulcerate. Microscopically, it is classified into blastic, immature and differentiated type and closely mimics malignant lymphoma both on cytology and tissue sections. Histological differentiation from lymphoma is possible on haematoxylin and eosin (H and E)-stained sections by a trained pathologist due to infiltrative pattern of the cells and characteristic multilobated nuclear configuration in myeloid sarcoma as compared to cleaved nuclear pattern in lymphoma. [9] Myeloperoxidase, naphthol ASD-chloroacetate esterase staining done on cytology smears aid in confirming the Vishalakshi V, et al.: Cutaneous manifestations in renal failure patients diagnosis, while on tissue sections chloroacetate esterase, anti-lysozyme, anti-myeloperoxidase, anti-CD68 and anti-CD43 staining help in demonstrating the myeloid morphology. [8, 10] Other markers include muramidase, alpha-1 anti trypsin, cathepsin G and leukocyte elastase. [10] In cases of aleukemic leukemia cutis, development of myeloid sarcoma preceding AML in peripheral blood may be due to the proliferation of myeloblasts in the spleen or lymph nodes and unexplained failure of release of myeloblasts from the
